Project Grant R35GM163889
- Federal Grant Award Summary The University of Delaware received a $500,000 Project Grant from the National Science Foundation's Division of Biological Infrastructure under the Biological Sciences program (CFDA 47.074), effective August 1, 2026 through July 31, 2029. This collaborative research award supports the development of innovative biotechnology tools for targeted proximity labeling of extracellular vesicles (EVs)—membrane-bound particles released by cellular organisms that carry...
- Federal Grant Award Summary The University of Delaware received a $1.36M Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded April 1, 2026, with completion scheduled for March 31, 2030. The research project investigates ADAM (disintegrin metalloproteinase) and ephrin interactions in cell signaling and adhesion mechanisms. The grant supports two primary research aims: (1) assessing the...
- Federal Project Grant Award Summary The University of Delaware received a $430,675 Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded September 15, 2025, with completion targeted for August 31, 2030. The award funds the Corbin Lab's research initiative titled "Probing Spatiotemporal Mechanobiology Through Novel Dynamic Material Platforms," which focuses on developing engineered...
- Federal Grant Award Summary The National Institute of General Medical Sciences (NIGMS) awarded the University of Delaware a $460,953 Project Grant effective March 1, 2026, through February 28, 2031, under the Biomedical Research and Research Training program (CFDA 93.859). The grant funds research investigating the subcellular transport, regulation, and function of ribonucleic acids (RNAs) during early embryonic development. The research centers on understanding how microRNA-31 (miR-31) is...
- Federal Grant Award Summary The University of Delaware received a $2.4 million Project Grant from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), awarded September 1, 2025, with a completion date of May 31, 2030. This Phase III Center of Biomedical Research Excellence (COBRE) award supports the continued discovery and development of chemical probes and lead molecules for biological research and therapeutic...
- Federal Project Grant Award Summary The University of Delaware received a $2.57 million Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective June 1, 2025, through February 28, 2030. This five-year Phase I Center of Biomedical Research Excellence (COBRE) grant funds the establishment of the Center for Biomedical Research Excellence in Multiscale Biomolecular Sensing (MBS), which...
- Federal Grant Award Summary The University of Delaware received a $279,964 Project Grant from the National Science Foundation (NSF) Directorate for Engineering (CFDA 47.041) effective September 1, 2026 through August 31, 2029. This collaborative research award supports the development of predictive computational models that characterize how the mechanical properties of soft nanoparticles interact with cell membrane mechanics to determine cellular uptake pathways. The primary deliverable is a...
- Federal Project Grant Award Summary The University of Delaware received a $300,000 Project Grant from the National Science Foundation's Division of Chemical, Bioengineering, Environmental, and Transport Systems (Engineering program, CFDA 47.041) effective September 1, 2025, through August 31, 2027, to develop synthetic biology tools for controlling macrophage immune cell phenotype through histone lactylation modulation. The primary deliverables include precision engineering tools—lactylation...
- Federal Grant Award Summary The University of Delaware received a $1.0 million Project Grant from the National Science Foundation's Division of Molecular and Cellular Biosciences under the Biological Sciences program (CFDA 47.074), effective July 1, 2026 through June 30, 2029. This research initiative, titled "Tools4Cells: Multi-Kingdom Acetyl-CoA Sensing for Real-Time Reporting and Control of Metabolism," develops protein-based biosensor technology to enable real-time monitoring of...
- Federal Project Grant Award Summary The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded the University of Delaware a $436,658 project grant under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) on August 7, 2025, to establish a stable production cell line for recombinant adenovirus-associated virus (rAAV) manufacturing. The primary deliverable addresses a critical gap in viral vector biomanufacturing by...
The University of Delaware received a $392,495 Project Grant award dated July 1, 2026, from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859). The award supports fundamental research into the mechanisms of extracellular vesicle (EV) biogenesis and uptake through February 28, 2031. The project delivers research findings and novel methodological tools that advance understanding of how cells release and utilize extracellular vesicles—small membrane-bound particles that mediate intercellular transport of bioactive molecules including proteins, RNA, and metabolites. This research has direct applications to understanding disease propagation in neurodegenerative, cardiovascular, and kidney diseases. The research deliverables include development of specialized Caenorhabditis elegans model strains with fluorescently-tagged EV cargoes and advanced imaging methods capable of quantitating EV shedding from specific neuronal cilia, measuring cargo abundance in releasing cilia, tracking glial uptake of EVs, and assessing cellular responses to EV shedding and uptake. The project investigates how conserved genes and cellular stress impact EV release, uptake, and function, utilizing live-organism imaging to capture EV biogenesis in native cellular environments. These research products contribute to the NIGMS mission of supporting basic research that increases understanding of biological processes and establishes the scientific foundation for advances in disease diagnosis and treatment.Federal Project Grant Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $392.5k | 6/24/26 |